Honeywell adds new ultra-fine denier fibre to portfolio
2023-02-09
Honeywell has added a new ultra-fine denier fibre to its Spectra Medical Grade (MG) BIO fibre portfolio.
Spectra Ultra Fine (UF) BIO fibre, now available in 25 decitex (dtex), enables minimally invasive cardiovascular and orthopaedic device design and helps increase device longevity.
Compared with conventional polyethylene fibre, Honeywell’s Spectra MG BIO fibres are made of ultra-high molecular weight polyethylene (UHMWPE), which is ultra-lightweight, ultra-high strength and manufactured through a gel spinning process, providing a biocompatible material that has strong resistance to chemicals, water, fatigue, friction, and abrasion.
Honeywell’s portfolio of Spectra MG BIO fibres are 15 times stronger than steel by weight and three times stronger than polyester by volume. Spectra MG BIO fibre has received ISO 13485 certification.
Zachary Murnane, medical fibre global business manager for Honeywell Spectra, said: “The introduction of Spectra UF BIO fibre in 25 dtex demonstrates Honeywell’s ongoing commitment to building a collection of medical grade fibres that support a wide range of medical device needs. Access to this technology is critical to enabling continued innovation that makes cardiovascular and orthopaedic procedures safer and more successful for patients worldwide. Honeywell continues to be a leading provider to healthcare companies helping to drive innovation in the life sciences industry.”
Honeywell’s new Spectra UF BIO fibre in 25 dtex will be commercially available globally within Q1 2023. A Spectra Ultra Fine BIO fibre in 10 dtex will be available later in the first half of 2023.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。